| Study Period | 2019 - 2030 |
| 2024 Market Size | USD 249.6 Million |
| 2025 Market Size | USD 266.8 Million |
| 2030 Forecast | USD 434.4 Million |
| Growth Rate (CAGR) | 9.7% |
| Largest Region | South |
| Fastest-Growing Region | West |
| Nature of the Market | Fragmented |
| Largest Application Category | Hospitals |
|
The U.S. body composition analyzers market will generate an estimated revenue of USD 249.6 million in 2024 and witness a CAGR of 9.7% during 2024–2030, reaching USD 434.4 million by 2030. This is because the number of obesity cases is increasing, the fitness business is expanding, and bioimpedance analyzers are becoming common in sports and athletics.
Body composition analyzers have medical applications including the diagnosis and treatment of diseases, such as sarcopenia, malnutrition, and chronic diseases.
Integration with digital health platforms, need of customers for miniaturization and portability, implementation of AI and ML, increasing health and fitness awareness, an aging population, the growing popularity of personalized nutrition and fitness plans, and the surging interest in sports and athletics are the main factors driving the market.
Want a report tailored exactly to your business need?
Request Customization
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages